1 Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
2 Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany.
3 Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
4 IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
5 MDS Unit, Hematology, AOU Careggi - Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
6 Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), AOU Careggi, Florence, Italy.
7 Laboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.
8 Deutsches Zentrum Immuntherapie and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
9 Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
10 Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
11 National Center for Tumor Diseases (NCT); German Cancer Research Center (DKFZ); Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
12 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
13 German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
14 German MDS Study Group (D-MDS), Leipzig, Germany.
15 Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. shahram.kordasti@kcl.ac.uk.
16 Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy. shahram.kordasti@kcl.ac.uk.